Skip to main content
| News

DayOne Accelerator finalizes participants

20.11.2019

BaselArea.swiss manages the DayOne initiative, which is now organizing the second round of the DayOne Accelerator. The participants are Digital Health startups promoting the health of children and young people.

DayOne Conference 2019

The DayOne Accelerator has chosen six participants, of whom four will receive non-dilutive funding of 50,000 Swiss francs, announced a statement. All the participants will benefit from BaselArea.swiss, which is providing support by connecting them to a network of potential partners and customers, including the particularly distinguished University Children’s Hospital Basel (UKBB).

A total of 120 startups applied to the competition, and 14 were shortlisted. These companies worked in part with UKBB to develop their business ideas, before six were chosen by a panel of experts from the region to progress to the accelerator. One of the participants is the Basel company Nutrix, which is developing a nanosensor for glucose monitoring in saliva to prevent diabetes. Virtual Doctors is another – a telemedicine company that supports healthcare professionals who provide care in Zambia.

The four companies that will receive a place on the program and financial support include the Basel company Zoundream , whose goal is to help identify the messages and potential pathologies in babies’ crying. Another is Haako, also Basel-headquartered, which is helping parents of children with asthma to better manage their condition. Rekonas (e Tomo), a spinoff from the University of Basel, is working on improved bedside monitoring of epilepsy. Finally, Wello Health is a Romanian company that helps families with overweight children to improve nutrition.

During the six-month program, the participants will learn from the accelerator – but the organizers will in turn learn from the startups’ developments, according to Fabian Streiff, Director Healthcare Innovation – DayOne at BaselArea.swiss. He said: “We understand that the process of taking a venture from a good idea to a viable venture in digital health is challenging and that these entrepreneurs need support.”

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Read More
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
1 2 3 35

Do you have a question? We'd like to hear from you.